ATRX Adhera Therapeutics Inc

Price (delayed)

$0.06

Market cap

$1.05M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.54

Enterprise value

$7.84M

Highlights
The net income has plunged by 159% YoY but it has grown by 19% from the previous quarter
Adhera Therapeutics's EPS has decreased by 32% YoY but it has increased by 17% QoQ
ATRX's equity has dropped by 64% year-on-year
The debt is up by 7% year-on-year and by 2.5% since the previous quarter

Key stats

What are the main financial stats of ATRX
Market
Shares outstanding
17.49M
Market cap
$1.05M
Enterprise value
$7.84M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$4.01M
EBITDA
-$4.01M
Free cash flow
-$835,000
Per share
EPS
-$0.54
Free cash flow per share
-$0.05
Book value per share
-$1.64
Revenue per share
$0
TBVPS
$0.01
Balance sheet
Total assets
$170,000
Total liabilities
$25.67M
Debt
$6.83M
Equity
-$25.5M
Working capital
-$25.5M
Liquidity
Debt to equity
-0.27
Current ratio
0.01
Quick ratio
0
Net debt/EBITDA
-1.69
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-5,390.3%
Return on equity
N/A
Return on invested capital
N/A
Return on capital employed
N/A
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ATRX stock price

How has the Adhera Therapeutics stock price performed over time
Intraday
1.52%
1 week
-14.29%
1 month
5.26%
1 year
-50%
YTD
-18.92%
QTD
-13.04%

Financial performance

How have Adhera Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$824,000
Net income
-$5.12M
Gross margin
N/A
Net margin
N/A
The net income has plunged by 159% YoY but it has grown by 19% from the previous quarter
Adhera Therapeutics's operating income has decreased by 22% QoQ

Growth

What is Adhera Therapeutics's growth rate over time

Valuation

What is Adhera Therapeutics stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Adhera Therapeutics's EPS has decreased by 32% YoY but it has increased by 17% QoQ
ATRX's equity has dropped by 64% year-on-year

Efficiency

How efficient is Adhera Therapeutics business performance
The ROA has grown by 37% from the previous quarter and by 36% YoY

Dividends

What is ATRX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ATRX.

Financial health

How did Adhera Therapeutics financials performed over time
ATRX's total assets is 99% smaller than its total liabilities
Adhera Therapeutics's total liabilities has surged by 66% YoY
ATRX's total assets is down by 13% since the previous quarter
The debt is 127% greater than the equity
ATRX's equity has dropped by 64% year-on-year
Adhera Therapeutics's debt to equity has increased by 34% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.